Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.
about
Superantigen antagonist peptidesStreptococcal necrotising fasciitis from diverse strains of Streptococcus pyogenes in tropical northern Australia: case series and comparison with the literatureAntimicrobial Treatment for Systemic Anthrax: Analysis of Cases from 1945 to 2014 Identified Through a Systematic Literature ReviewUse of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracisStreptococcus pyogenes biofilms-formation, biology, and clinical relevancePediatric anthrax clinical managementTropical primary pyomyositis in children of the UK: an emerging medical challengeDisease manifestations and pathogenic mechanisms of Group A Streptococcus.Practice guidelines for the diagnosis and management of skin and soft-tissue infections.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.Host gene expression profiling and in vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis model.Current concepts in the management of necrotizing fasciitis.Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infectionDifferential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system.Molecular diagnosis of necrotizing fasciitis by 16S rRNA gene sequencing and superantigen gene detection.Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model.Treatment options in the management of necrotising fasciitis caused by Group A Streptococcus.Necrotizing fasciitis resulting from human bites: A report of two cases of disease caused by group A streptococcusZoonotic necrotizing myositis caused by Streptococcus equi subsp. zooepidemicus in a farmer.Therapies for necrotising fasciitis.Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.Characteristics of group A Streptococcus strains circulating during scarlet fever epidemic, Beijing, China, 2011.Therapeutic considerations for children with invasive group a streptococcal infections: a case series report and review of the literature.Update on clindamycin in the management of bacterial, fungal and protozoal infections.Surviving streptococcal toxic shock syndrome: a case reportPostpartum invasive group A streptococcal disease in the modern era.Infectious shock and toxic shock syndrome diagnoses in hospitals, Colorado, USAGenetic commonality of macrolide-resistant group A beta hemolytic streptococcus pharyngeal strains.Adjunctive clindamycin for cellulitis: a clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitisDiagnosis and management of skin and soft-tissue infections (SSTI): a literature review and consensus statement on behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy.The efficacy and safety of antibiotic combination therapy for infections caused by Gram-positive and Gram-negative organisms.Monomicrobial Pseudomonas necrotizing fasciitis: a case of infection by two strains and a review of 37 cases in the literature.Intravenous antibiotics used in dermatology.Invasive group a streptococcal disease: epidemiology, pathogenesis and management.Diagnosis and treatment of invasive group A streptococcal infections.Bacterial meningitis: new therapeutic approaches.Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies.Necrotizing Fasciitis and The Diabetic Foot.
P2860
Q24795896-1A759D91-0A81-4A00-8B2E-BA549077F51CQ24799782-D8819C47-3DD8-4054-B5E5-093216D5C5FFQ28383825-E202893C-FD2F-41F6-879B-FE51BBFAF2A8Q28384759-0460905F-1698-4167-85AC-6BD0837A6752Q28387682-52533F1F-D732-43E1-916D-CDD0466C6EECQ28397091-97F6E261-3FC7-4DF2-9886-26192C6148A3Q33971494-16EDD870-36A1-4E0F-A90E-4CCD3707A1DAQ34413457-4C0C2A71-F788-4B52-8C0C-C9448064B971Q34460523-1DF338D3-BA2E-4445-952C-3382CE90FEB7Q34478074-E21E01E6-6759-40A1-9DAE-AFB75E56E9C3Q34487226-DA353979-A7B5-4087-AEB2-5DDD70292474Q34487628-1D2652C4-F042-4EDF-AD97-26FC13F8383DQ34658467-A7D1B669-4122-4B1C-B4A3-679B2F6D61FBQ34868108-6EA0A86E-E580-4ABE-B86B-217C761133F6Q35222098-D5EA3CB1-A3C0-4E93-85B4-DF5DA3DA206FQ35666418-0A31DE7A-9A68-473F-A861-97FFED6B4851Q35790016-3CE486C4-E7FA-41DD-B9A5-30D11AA0F547Q35806278-7D73110C-B459-4D19-86DC-82A752E144A4Q35841570-32698963-257B-4BD2-B2CF-C0241C4B6518Q36171077-F99C4022-69D9-4C60-82EA-74E824123C81Q36281617-363B248D-0F23-47D6-9F4D-21608C987B74Q36377217-A8534D6D-1742-44BD-8447-AFCE9120C5FEQ36423634-B5331094-F764-47A8-88C8-ABF1CC559833Q36752322-FD0C600D-6715-4B76-AAC9-EB6E97EE47DEQ36853382-71F93ED1-BD68-4647-A5BB-3172834D847DQ36967293-E3E731BB-B73C-4645-B89B-BC52089E68ABQ36984266-B56B3DEF-0CAB-4B65-9F15-15F2FDB6D068Q37034250-01FC0594-FE51-4E28-A616-7C93FDC780DAQ37335162-E81E23F5-6E4E-4FF8-B938-BB95C7FCF87DQ37465643-7B9C6A56-4EA8-4F4E-80D8-EACE3E7856A5Q37728410-33C21169-9F2D-46A5-8ADD-45CE0BCE0DFDQ37946595-B81AB455-F5C4-4BCE-A251-51AB5D33F7CFQ37954711-CA7889B7-F84F-4114-A98F-DA584C69315AQ37962626-1B8C83D5-7995-4627-BCAC-EC72CE73CA6EQ38010520-318508A0-22B4-40B3-AB0C-A009CF54D2A5Q38017734-424CB90E-FD69-4CCB-A3CC-08336481684CQ38089734-AEBCA9D0-979E-49BA-80FE-A31C70929387Q38145360-CCF60AA3-83A5-4925-AD6A-F05BD034126AQ38369044-362024D4-88E7-4F56-B8E2-1CC4843EA53FQ38594750-784AB420-1E78-4D54-AD82-FBAE84F8507F
P2860
Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Improved outcome of clindamyci ...... eptococcus pyogenes infection.
@ast
Improved outcome of clindamyci ...... eptococcus pyogenes infection.
@en
type
label
Improved outcome of clindamyci ...... eptococcus pyogenes infection.
@ast
Improved outcome of clindamyci ...... eptococcus pyogenes infection.
@en
prefLabel
Improved outcome of clindamyci ...... eptococcus pyogenes infection.
@ast
Improved outcome of clindamyci ...... eptococcus pyogenes infection.
@en
P2093
P1476
Improved outcome of clindamyci ...... eptococcus pyogenes infection.
@en
P2093
P304
P356
10.1097/00006454-199912000-00014
P577
1999-12-01T00:00:00Z